Minerva Neurosciences, Inc. Increase (Decrease) in Other Noncurrent Liabilities
Minerva Neurosciences, Inc. (NERV) reported Increase (Decrease) in Other Noncurrent Liabilities of -$888 for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2020-03-09
- Minerva Neurosciences, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2018-12-31 was -$1.09K.
- Minerva Neurosciences, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2018-09-30 was -$592.00.
- Minerva Neurosciences, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2018-06-30 was $395.00.
- Minerva Neurosciences, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2018-03-31 was $395.00.
- Minerva Neurosciences, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2018 was -$888.00, a 102.97% decline from fiscal 2017.
- Minerva Neurosciences, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2017 was $29.88K.
- Minerva Neurosciences, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2015 was -$7.69K, a 200.00% decline from fiscal 2014.
- Minerva Neurosciences, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2014 was $7.69K.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$1.09K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | -$1.68K derived: sum of 2 quarters · filed 2020-03-09 | -$1.28K derived: sum of 3 quarters · filed 2020-03-09 | -$888.00 10-K · filed 2020-03-09 |
| 2018-09-30 | -$592.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | -$197.00 derived: sum of 2 quarters · filed 2019-11-04 | $198.00 10-Q · filed 2019-11-04 | |
| 2018-06-30 | $395.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $790.00 10-Q · filed 2019-08-05 | ||
| 2018-03-31 | $395.00 10-Q · filed 2019-05-06 | |||
| 2017-12-31 | $29.88K 10-K · filed 2019-03-12 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$2.56K derived: sum of 2 quarters · filed 2018-03-12 | -$5.13K derived: sum of 3 quarters · filed 2018-03-12 | -$7.69K 10-K · filed 2018-03-12 |
| 2015-09-30 | -$2.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$5.13K derived: sum of 2 quarters · filed 2016-11-03 | -$7.69K 10-Q · filed 2016-11-03 | |
| 2015-06-30 | -$2.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$5.13K 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | -$2.56K 10-Q · filed 2016-05-03 | |||
| 2014-12-31 | $7.69K 10-K · filed 2017-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |